Although ORF23 is conserved among gammaherpesviruses, its role during infection is unknown. Here, we studied the expression of ORF23 of murine gammaherpesvirus 68 (MHV-68) and its role during infection. ORF23 mRNA was detected in infected cells as a late transcript. The ORF23 protein product could be expressed and detected as an N-terminally FLAG-tagged protein by Western blot and indirect immunofluorescence. To investigate the role of ORF23 in the infection cycle of a gammaherpesvirus, we constructed an ORF23 deletion mutant of MHV-68. The analysis of the ORF23 deletion mutant suggested that ORF23 of MHV-68 is neither essential for replication in cell culture nor for lytic or latent infection in vivo. A phenotype of the ORF23 deletion mutant, reflected by a moderate reduction in lytic replication and latency amplification, was only detectable in the face of direct competition to the parental virus.
Murine gammaherpesvirus 68 (MHV-68) is a member of the gammaherpesviruses and closely related to the human gammaherpesviruses Kaposi's sarcoma-associated herpesvirus (KSHV) and Epstein-Barr virus (EBV) (Virgin et al., 1997) . MHV-68 serves as a small animal model to investigate gammaherpesvirus pathogenesis (Barton et al., 2011; Blackman & Flaño, 2002; Nash et al., 2001; Simas & Efstathiou, 1998; . The nucleotide sequence of MHV-68 is similar to EBV and even more closely related to KSHV (Virgin et al., 1997) . In addition to virus-specific genes, MHV-68 contains genes that are homologous to cellular genes or to genes of other gammaherpesviruses. One of the latter is ORF23. Although being conserved among gammaherpesviruses, the function of ORF23 is unknown. Here, we studied the expression of ORF23 of MHV-68 and explored an ORF23 deletion mutant to investigate the role of ORF23 in the infection cycle of a gammaherpesvirus.
To analyse the expression of ORF23 at the mRNA level, the persistently infected cell line S11 (Usherwood et al., 1996) was treated with 20 ng 12-O-tetradecanoyl-phorbol-13-acetate (TPA) ml 21 to induce the lytic cycle, and expression of ORF23 was examined by real-time RT-PCR. Expression of ORF23 mRNA was readily inducible by TPA stimulation (Fig. 1a) . In addition, we analysed the expression of ORF23 mRNA after infection of NIH3T3 cells in the presence or absence of either the protein synthesis inhibitor cycloheximide (CHX; 10 mg ml
21
) or the DNA synthesis inhibitor phosphonoacetic acid (PAA; 200 mg ml
). Treatment with CHX or PAA strongly reduced expression of ORF23 mRNA and thus allowing classification as a late transcript (data not shown). Next, we wanted to analyse the expression and intracellular localization of ORF23 at the protein level. For this purpose, the predicted ORF (Virgin et al., 1997) was cloned as an N-terminally FLAG-tagged protein into the eukaryotic expression vector pCA7, a derivative of pCAGGS (Niwa et al., 1991) . After transient transfection, expression of the FLAG-tagged ORF23 protein (FLAG-ORF23) could be demonstrated both by Western blot (Fig. 1b) and by immunofluorescence microscopy (Fig. 1c) by using an anti-FLAG antibody. In immunofluorescence analysis, the protein displayed both a nuclear and a cytoplasmic localization with a dotted pattern. To test whether the presence of additional viral proteins might change the localization of the ORF23 protein, cells were transiently transfected with plasmid DNA and simultaneously infected with BAC-derived, GFP-expressing MHV-68. The localization of the ORF23 protein did not change after infection (Fig. 1d) .
To investigate the role of ORF23 in the infection cycle, we constructed an ORF23 deletion mutant (D23) with a deletion of nucleotides 37 226-37 766 [ Fig. S1(a) and Supplementary Methods, available in JGV Online]. To exclude the possibility that a potential phenotype of the ORF23 deletion mutant might be due to rearrangements outside the mutated region, a revertant (23R) of the ORF23 deletion mutant was also generated. The BAC-cloned genomes were analysed by restriction enzyme analysis with several restriction enzymes [ Fig. S1(b) ]. Viruses were reconstituted and the BAC cassette was removed as described previously (Adler et al., 2000) . The genomes of the reconstituted viruses were also analysed by restriction enzyme and Southern blot analyses [ Fig. S1(c) ].
Transfection of the ORF23 mutant BAC plasmid into BHK-21 cells led to the development of plaques, indicating that ORF23 is not essential for lytic replication in vitro (data not shown). This is consistent with earlier findings by others (Song et al., 2005) . To determine the in vitro growth kinetics of the recombinant viruses, multi-step growth curves were performed in two different murine cell lines, NIH3T3 (fibroblasts) [ Fig. S2 To analyse lytic growth of the recombinant viruses in mice, C57BL/6 or BALB/c mice were infected intranasally (i.n.) or intraperitoneally (i.p.) with 1610 5 p.f.u. of the indicated viruses. Virus titres were determined from lung and spleen homogenates by plaque assay on BHK-21 cells at days 6 and 9 after infection, respectively. As shown in Fig. 2 (a), deletion of ORF23 did not affect lytic virus replication in vivo. Lungs were also analysed at days 3 and 10 after i.n. infection. Similar to day 6, we did not observe significant differences (data not shown). Since we did not observe differences after infection with 1610 5 p.f.u., we performed an additional experiment with a 100-fold lower dose. Five C57BL/6 mice per group (parental virus, D23 and 23R) were infected i.n. with 1000 p.f.u., and virus titres were determined from lung homogenates at day 6 after infection. Again, no differences were observed (data not shown).
To analyse latent infection, mice were infected with 1610 5 p.f.u. as described above. At day 17 ('early latency'), spleens were harvested and single-splenocyte suspensions were 
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prepared and analysed in an ex vivo reactivation assay (Adler et al., 2001) . No significant differences were observed (Fig.  2b) . We also determined the viral genomic load from the same samples using quantitative real-time PCR (Flach et al., 2009) . Again, no significant differences were observed (Fig.  2c) . The viral genomic load in the spleen was also analysed at day 42 ('late latency') after i.n. or i.p. infection. As at day 17, we did not observe significant differences (data not shown). Finally, we analysed latency in peritoneal exudate cells (PECs). C57BL/6 mice were infected i.p., PECs were harvested 17 days after infection and the number of ex vivo reactivating cells and the viral genomic load were determined. As shown in Fig. 2(d) , no significant differences were observed. Thus, ORF23 appeared to be dispensable for establishment and maintenance of latency as well as for reactivation from latency at least after infection with 1610 5 p.f.u. Therefore, we again performed an additional experiment with a 100-fold lower dose. Five C57BL/6 mice per group (parental virus, D23 and 23R) were infected i.n. with 1000 p.f.u., and the number of ex vivo reactivating cells and the viral genomic load were determined 17 days after infection. Again, no differences were observed (data not shown). We also performed a recently established, so-called non-invasive upper respiratory tract (nose) infection (Milho et al., 2009) . To this end, we infected five C57BL/6 mice per group and time point i.n. with 1000 p.f.u. of parental virus, D23 mutant and revertant without anaesthesia. Lungs were analysed at days 5 and 8 after infection for lytic virus, and spleens were analysed at days 17 and 42 after infection for latent virus by the assays described above. Consistent with a previous report (Milho et al., 2009 ), infection did not reach the lung, but virus delivered to the nose still established normal persistence in the spleen as determined by quantitative real-time PCR at day 42 after infection. However, again we observed no differences between the groups (data not shown).
So far, using the standard assays, we could neither detect a role of ORF23 during lytic infection nor during latency. However, we hypothesized that the situation might be different if mutant and parental virus are put in direct competition by co-infection. For this purpose, C57BL/6 mice were i.n. co-infected with 1000 p.f.u. of parental virus and additionally of D23 mutant. Lungs and spleens were harvested at various time points after infection, and DNA was isolated for real-time PCR analysis by using virusspecific primers to determine the viral load of each virus. In the face of virus competition, the D23 mutant showed a moderate but significant reduction both during lytic replication ( Fig. 3a ; days 3 and 6 after infection) and latency amplification ( Fig. 3b ; day 17 after infection).
In this study, we investigated the role of ORF23 in the infection cycle of MHV-68. Our analysis of mRNA expression allowed us to classify the ORF23 mRNA as a late transcript, consistent with previous reports (Ahn et al., 2002; Ebrahimi et al., 2003; Johnson et al., 2010; MartinezGuzman et al., 2003) . Cloning of the predicted ORF (Virgin et al., 1997) (Johannsen et al., 2004) , KSHV (Bechtel et al., 2005) and MHV-68 (Bortz et al., 2003) .
The analysis of an ORF23 deletion mutant suggested that ORF23 of MHV-68 is neither essential for replication in cell culture nor for lytic or latent infection in vivo. It is important to highlight that we made our observations after infection of two different mouse strains (C57BL/6 and BALB/c) and by using two different routes of infection (i.n. and i.p.). Furthermore, we analysed two different compartments of lytic replication (lung and spleen) and two different compartments of latency (spleen and PECs). It is known that mouse strain, the route of infection and the compartments analysed may all influence the outcome of an infection with a particular mutant (Barton et al., 2011) . A phenotype of the ORF23 deletion mutant, reflected by a moderate reduction in lytic replication and latency amplification, was only detectable when it was, by co-infection, placed in direct competition to the parental virus. There might be several reasons why we did not observe a more pronounced phenotype of the ORF23 deletion mutant: (i) it is possible that deletion of ORF23 alone is not sufficient to Fig. 3 . In vivo co-infection experiments. C57BL/6 mice were i.n. co-infected with 1000 p.f.u. of each of the indicated viruses. Lungs (left panel) or spleens (right panel) were harvested at the indicated time points and DNA was isolated from the tissues. Real-time PCR analysis with virus-specific primers was performed as described in the Supplementary Methods. Each symbol represents an individual mouse and the bars represent the mean. The data are depicted as relative viral load, and the unpaired Student's t-test was used for statistical analysis.
generate a phenotype because other viral genes might complement the loss of ORF23; (ii) although ORF23 does not seem to be required for infection in our experimental settings, it might be required for infection parameters we are not able to measure, such as, for example, virus transmission.
Taken together, the precise role of ORF23 during infection remains elusive and further studies will be required to elucidate its function.
